Enzo Biochem, Inc.

LSE:0IHV Rapport sur les actions

Capitalisation boursière : US$59.0m

Enzo Biochem Gestion

Gestion contrôle des critères 0/4

Enzo Biochem's CEO is Kara Cannon, appointed in Sep 2023, has a tenure of 1.17 years. total yearly compensation is $1.22M, comprised of 24.4% salary and 75.6% bonuses, including company stock and options. directly owns 0.53% of the company’s shares, worth $311.29K. The average tenure of the management team and the board of directors is 1.2 years and 1.1 years respectively.

Informations clés

Kara Cannon

Directeur général

US$1.2m

Rémunération totale

Pourcentage du salaire du PDG24.4%
Durée du mandat du directeur général1.2yrs
Propriété du PDG0.5%
Durée moyenne d'occupation des postes de direction1.2yrs
Durée moyenne du mandat des membres du conseil d'administration1.1yrs

Mises à jour récentes de la gestion

Recent updates

Analyse de la rémunération des PDG

Comment la rémunération de Kara Cannon a-t-elle évolué par rapport aux bénéfices de Enzo Biochem?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jul 31 2024n/an/a

-US$10m

Apr 30 2024n/an/a

-US$18m

Jan 31 2024n/an/a

-US$23m

Oct 31 2023n/an/a

-US$25m

Jul 31 2023US$1mUS$299k

-US$25m

Apr 30 2023n/an/a

-US$27m

Jan 31 2023n/an/a

-US$24m

Oct 31 2022n/an/a

-US$23m

Jul 31 2022US$769kUS$270k

-US$20m

Apr 30 2022n/an/a

-US$7m

Jan 31 2022n/an/a

US$300k

Oct 31 2021n/an/a

US$5m

Jul 31 2021US$426kUS$265k

US$8m

Apr 30 2021n/an/a

US$1m

Jan 31 2021n/an/a

-US$11m

Oct 31 2020n/an/a

-US$21m

Jul 31 2020US$371kUS$220k

-US$29m

Apr 30 2020n/an/a

-US$31m

Jan 31 2020n/an/a

US$2m

Oct 31 2019n/an/a

US$822k

Jul 31 2019US$379kUS$220k

US$2m

Apr 30 2019n/an/a

US$2m

Jan 31 2019n/an/a

-US$23m

Oct 31 2018n/an/a

-US$16m

Jul 31 2018US$342kUS$198k

-US$10m

Rémunération vs marché: Kara's total compensation ($USD1.22M) is above average for companies of similar size in the UK market ($USD369.71K).

Rémunération et revenus: Kara's compensation has increased whilst the company is unprofitable.


PDG

Kara Cannon (55 yo)

1.2yrs

Titularisation

US$1,221,793

Compensation

Ms. Kara Cannon serves as Chief Executive Officer at Enzo Biochem, Inc. from January 31, 2024 and serves as its Director from 2024 and served as its Interim CEO since September 5, 2023 until January 31, 20...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Kara Cannon
CEO & Director1.2yrsUS$1.22m0.53%
$ 311.3k
Patricia Eckert
Chief Financial Officer2yrsUS$453.56k0.037%
$ 21.9k
Brian Fisher
General Counselless than a yearpas de donnéespas de données

1.2yrs

Durée moyenne de l'emploi

53yo

Âge moyen

Gestion expérimentée: 0IHV's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Kara Cannon
CEO & Directorless than a yearUS$1.22m0.53%
$ 311.3k
Steven Pully
Independent Chairperson of the Board1.1yrspas de données0.034%
$ 20.0k
Bradley Radoff
Independent Director2.8yrsUS$195.00k8.07%
$ 4.8m

1.1yrs

Durée moyenne de l'emploi

55yo

Âge moyen

Conseil d'administration expérimenté: 0IHV's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.